SCHEMBL487057

SCHEMBL487057

C[N+](C)(CCN(CCc1ccc(C(=O)c2ccccc2)cc1)CCN(CCc1ccc(C(=O)c2ccccc2)cc1)CC[N+](C)(C)Cc1ccc(C(=O)c2ccccc2)cc1)Cc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.46
GLI1 P08151 2/20 0.40
GLI2 P10070 2/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SRD5A2 P31213 2/20 0.38
BCHE P06276 1/20 0.38
MLYCD O95822 1/20 0.38
ALOX5 P09917 1/20 0.38
PPARG P37231 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ATM Q13315 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL321585 0.99 ACHE (0.46) ACHEGLI1GLI2ALDH1A1HPGD
Bromide SCHEMBL231807 0.97 ACHE (0.44) ACHEGLI1GLI2ALDH1A1HPGD
Bromide SCHEMBL232864 0.96 ACHE (0.45) ACHEGLI1GLI2ALDH1A1HPGD
Bromide SCHEMBL6055901 0.91 ACHE (0.43) ACHEGLI1GLI2ALDH1A1HPGD
SCHEMBL28202434 0.83 SRD5A2 (0.45) ACHEALDH1A1HPGDNPC1RAB9A
SCHEMBL485968 0.83 ALDH1A1 (0.50) ACHEALDH1A1HPGDNPC1RAB9A
Bromide SCHEMBL231675 0.81 ALDH1A1 (0.48) ACHEALDH1A1HPGDNPC1RAB9A
SCHEMBL5051511 0.80 ACHE (0.56) ACHEHPGDNPC1RAB9ABCHE
SCHEMBL16731588 0.80 DNM1 (0.51) ACHEALDH1A1HPGDNPC1RAB9A
Bromide SCHEMBL4003015 0.80 ACHE (0.45) ACHEALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503813-B1 SILANE COATING COMPOSITION SURMODICS INC (US) 2007-05-30 EP claimed
US-6706408-B2 Silane coating composition SURMODICS, INC. 2004-03-16 US claimed
US-20030215649-A1 First coating layer of a silane compound, a hydrolysis reaction product of the silane compound or a polymeric silane compound, or mixture (free of sulfide group), a second layer of a polymer and a photoactivable crosslinker SURMODICS, INC. 2003-11-20 US claimed
WO-2026090506-A1 MEDICAL DEVICE COATINGS AND METHODS SURMODICS, INC. (US) 2026-04-30 WO disclosed
US-20260108663-A1 LOW PARTICULATE LUBRICIOUS COATING WITH VINYL PYRROLIDONE AND ACIDIC POLYMER-CONTAINING LAYERS SURMODICS INC (US) 2026-04-23 US disclosed
US-20260108662-A1 LUBRICIOUS COATING FOR MEDICAL DEVICE SURMODICS INC (US) 2026-04-23 US disclosed
US-12472288-B2 Lubricious coating for medical device SURMODICS, INC. (US) 2025-11-18 US disclosed
EP-4082598-B1 LOW-FRICTION SEALING DEVICES SURMODICS INC (US) 2025-10-01 EP disclosed
US-12409253-B2 Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers SURMODICS, INC. (US) 2025-09-09 US disclosed
US-20250229008-A1 DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES BANK OF MONTREAL, AS COLLATERAL AGENT 2025-07-17 US disclosed
US-20250144182-A1 ACTIVE AGENT DEPOTS FORMED IN SITU FOR MAINTAINING LONG-TERM LESION PATENCY BANK OF MONTREAL, AS COLLATERAL AGENT 2025-05-08 US disclosed
US-20070054127-A1 SILANE COATING COMPOSITIONS, COATING SYSTEMS, AND METHODS Surmodics Coatings, LLC 2007-03-08 US disclosed
WO-2006130776-A2 HYDROPHILIC POLYMERIC COATINGS FOR MEDICAL ARTICLES SURMODICS, INC. (US) 2006-12-07 WO disclosed
US-20060276894-A1 Hydrophilic polymeric coatings for medical articles SURMODICS, INC. 2006-12-07 US disclosed
WO-2006099470-A2 COMPLIANT POLYMERIC COATINGS FOR INSERTABLE MEDICAL ARTICLES SURMODICS, INC. (US) 2006-09-21 WO disclosed
US-20060210816-A1 Compliant polymeric coatings for insertable medical articles BANK OF MONTREAL, AS COLLATERAL AGENT 2006-09-21 US disclosed
EP-1503813-A1 SILANE COATING COMPOSITION SurModics, Inc. (US) 2005-02-09 EP disclosed
US-6706408-B2 Silane coating composition SURMODICS, INC. 2004-03-16 US disclosed
WO-2003097117-A1 SILANE COATING COMPOSITION SURMODICS, INC. (US) 2003-11-27 WO disclosed
US-20030215649-A1 First coating layer of a silane compound, a hydrolysis reaction product of the silane compound or a polymeric silane compound, or mixture (free of sulfide group), a second layer of a polymer and a photoactivable crosslinker SURMODICS, INC. 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250144182-A1 ACTIVE AGENT DEPOTS FORMED IN SITU FOR MAINTAINING LONG-TERM LESION PATENCY PLAT, VEGFA, FGB ACHE 2276/4885GLI1 1078/4885GLI2 3176/4885
US-20260108662-A1 LUBRICIOUS COATING FOR MEDICAL DEVICE MUC1, ADH1A, PTK2 ACHE 1657/4885GLI1 1102/4885GLI2 2630/4885
US-20250229008-A1 DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES AHR, KRT18, CD44 ACHE 845/4885GLI1 1399/4885GLI2 2932/4885
US-20260108663-A1 LOW PARTICULATE LUBRICIOUS COATING WITH VINYL PYRROLIDONE AND ACIDIC POLYMER-CONTAINING LAYERS VCL, RAD54L, SELP ACHE 3530/4885GLI1 3068/4885GLI2 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.